BetterLife Pharma Inc.
Datakwaliteit: 67%
BETRF
OTC
Manufacturing
Chemicals
€ 0,04
▼
€ 0,01
(-15,69%)
Marktkapitalisatie: 6,53 M
Prijs
€ 0,04
Marktkapitalisatie
6,53 M
Dagbereik
€ 0,04 — € 0,04
52-Weeksbereik
€ 0,03 — € 0,09
Volume
2.500
Openen € 0,04
50D / 200D Gem.
€ 0,05
5,49% below
50D / 200D Gem.
€ 0,05
15,85% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -5,63 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,15
Interest CoverageN/A
Waardering
P/E Ratio
N/A
P/B Ratio1,90
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | — | -1,5 |
| P/B | 1,9 | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -5,63 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,15 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -3,09 M | Tangible Book Value | -3,09 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | 1,90 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -86,17% | ||
| Market Cap | 6,53 M | Enterprise Value | 6,12 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0,04 | OCF / Share | -0,04 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | -5,63 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | — | -121.182,0 | -6,28 M | -8,58 M | — |
| EPS (Diluted) | — | — | — | -0,11 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | -1,05 M | -6,02 M | -8,59 M | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 70.304,0 | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 322,0 | 322,0 | — |
| Interest Expense | — | 27.385,0 | 11.661,0 | 64.888,0 | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2018 | FY2017 | FY2016 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Total Assets | 383.817,0 | 132.658,0 | 106.115,0 | 3.844,0 | 3.844,0 |
| Total Liabilities | 429.200,0 | — | 435.104,0 | 1,03 M | 1,03 M |
| Shareholders' Equity | -45.383,0 | -1,47 M | -328.989,0 | -1,02 M | -1,02 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 64.511,0 | 112.421,0 | 71.639,0 | 2.061,0 | 15.037,0 |
| Current Assets | 149.253,0 | 129.758,0 | 103.215,0 | 2.061,0 | 2.061,0 |
| Current Liabilities | — | 1,61 M | — | 866.265,0 | 866.265,0 |
{"event":"ticker_viewed","properties":{"ticker":"BETRF","listing_kind":"stock","pathname":"/stocks/betrf","exchange":"OTC","country":"US"}}